Racial/ethnic differences in average CA125 and CA15.3 values and its correlates among postmenopausal women in the USA
- 18 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Causes & Control
- Vol. 32 (3), 299-309
- https://doi.org/10.1007/s10552-020-01384-z
Abstract
Purpose Among healthy postmenopausal women, levels of CA125 and CA15.3 are influenced by demographic and reproductive factors, including race/ethnicity. In this study, we sought to examine the interaction between race/ethnicity and other correlates of these biomarkers and whether the racial differences observed are simply determined by other correlates with racial differences. Methods In archived sera from 946 postmenopausal women who participated in the 2001–2002 cycle of the National Health and Nutrition Examination Survey, we measured CA125 and CA15.3 and examined their associations with health survey and examination data available in this cohort. We used multivariable linear regression to examine the association between CA125 and CA15.3 and race/ethnicity. We then calculated geometric means of these markers by demographic and reproductive factors stratified by race/ethnicity and used likelihood ratio tests to evaluate heterogeneity. Results Non-white race was associated with lower CA125, with Non-Hispanic Black women being associated with − 29.0% (95% CI − 42.5%, − 12.2%) difference and Mexican American women being associated with − 6.4% (95% CI − 18.1%, 6.9%) difference on average compared to Non-Hispanic White women. Associations between CA125 and age and parity varied by race/ethnicity. Non-Hispanic Black women were associated with higher CA15.3 compared to Non-Hispanic White women, with 17.3% (95% CI − 0.5%, 38.3%) differences on average. Associations between CA15.3 and age, number of births, and age at natural menopause varied by race/ethnicity. Conclusions Among postmenopausal women, Non-Hispanic Black women were associated with lower CA125 and higher CA15.3 levels compared to Non-Hispanic White women. Our results support that race/ethnicity should be considered when assigning thresholds for these biomarkers being tested for diagnostic or screening purposes.Keywords
Funding Information
- National Cancer Institute (R01 CA 158119, R35 CA197605, R01 CA193965)
- Minnesota Ovarian Cancer Alliance
This publication has 22 references indexed in Scilit:
- Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian TumorsObstetrics & Gynecology, 2011
- Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial SpecimensCancer Prevention Research, 2011
- A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian CancerCancer Prevention Research, 2011
- CA 15-3: Uses and limitation as a biomarker for breast cancerClinica Chimica Acta; International Journal of Clinical Chemistry, 2010
- Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic massAmerican Journal of Obstetrics and Gynecology, 2010
- American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast CancerJournal of Clinical Oncology, 2007
- Incessant Ovulation, Mucin 1 Immunity, and Risk for Ovarian CancerCancer Epidemiology, Biomarkers & Prevention, 2007
- Serum tumor marker immunoassays in gynecologic oncology: Establishment of reference valuesAmerican Journal of Obstetrics and Gynecology, 1996
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Percentage Points for a Generalized ESD Many-Outlier ProcedureTechnometrics, 1983